Stacy A. Kahn, MD
Director, Fecal Microbiota Transplantation; Gastroenterologist, Division of Gastroenterology, Hepatology and Nutrition
Associate Professor of Pediatrics, Harvard Medical School
Image
Stacy A. Kahn, MD
Director, Fecal Microbiota Transplantation; Gastroenterologist, Division of Gastroenterology, Hepatology and Nutrition
Associate Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
New York University School of Medicine
2001
New York
MA
Residency
University of Chicago
2004
Chicago
IL
Fellowship
University of Chicago
2008
Chicago
IL
Media
Managing Medical Issues
Looking for Answers: The Microbiome in Autism
Certifications
American Board of Pediatrics (Gastroenterology)
Professional History
Dr. Stacy Kahn completed her undergraduate degree in history at Washington University in St. Louis, and her post-baccalaureate premedical training at Bryn Mawr College in Pennsylvania. She attended New York University School of Medicine and then went on to complete her pediatric residency and pediatric gastroenterology fellowship at the University of Chicago. While at the University of Chicago, she also completed an ethics fellowship at the Maclean Center for Clinical Medical Ethics.
Clinically, Dr. Kahn’s interests have focused on the care of children with IBD, in particular she is interested in the care and management of teens and young adults with Crohn’s and colitis. While on the faculty at the University of Chicago, she founded and was the Director for the Transitional IBD Clinic. Dr. Kahn's other primary clinical focus is recurrent and refractory Clostridium difficile infection. She is a national expert and leader in the field of fecal microbiota transplantation (FMT) and performed the first colonoscopic FMT in a child.
Dr. Kahn's research interests include FMT for Clostridium difficile, FMT for inflammatory bowel disease, transition of care and self-management in IBD and research ethics. She is the director of the FMT research program at Boston Children’s Hospital and has led the development of the first national pediatric FMT registry.
Publications
Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease. View Abstract
Fecal Microbiota Transplantation: Information for the Pediatrician. View Abstract
Fecal Microbiota Transplant in Pediatric Solid Organ Transplant Recipients. View Abstract
Redefining Clostridioides difficile infection antibiotic response and clinical outcomes. View Abstract
How to Write an Effective Letter of Medical Necessity. View Abstract
Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after Fecal Microbiota Transplant in Inflammatory Bowel Disease. View Abstract
Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients. View Abstract
Case 3-2023: A 16-Year-Old Girl with Abdominal Pain and Bloody Diarrhea. View Abstract
Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation. View Abstract
Breaking Down the Boxes-Time to Reshape Demographic Data. View Abstract
Clostridioides difficile Infection in Hospitalized Pediatric Patients: Comparisons of Epidemiology, Testing, and Treatment from 2013 to 2019. View Abstract
Denials, Dilly-dallying, and Despair: Navigating the Insurance Labyrinth to Obtain Medically Necessary Medications for Pediatric Inflammatory Bowel Disease Patients. View Abstract
Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease. View Abstract
Pediatric Fecal Microbiota Transplantation in Recurrent Clostridioides Difficile. View Abstract
Fecal Microbiota Transplantation for Ulcerative Colitis: Dispelling the "Yuck Factor". View Abstract
Updates and Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. View Abstract
Current Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. View Abstract
Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location. View Abstract
Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations. View Abstract
Inflammatory Bowel Disease Presenting With Concurrent COVID-19 Multisystem Inflammatory Syndrome. View Abstract
The Ethics of Feeding the Aspirating Child in an Age of Increasing Patient Complexity. View Abstract
Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry. View Abstract
The Ethics of Feeding the Aspirating Child in an Age of Increasing Patient Complexity. View Abstract
Letter: is unrealised adult height resulting from paediatric Crohn's disease associated with a potential reduction in lifetime earnings? View Abstract
Perceived effect of pediatric inflammatory bowel diseases on academics, college planning, and college adjustment. View Abstract
Is it unethical to conduct placebo-controlled trials of faecal microbiota transplantation for recurrent Clostridioides difficile infection? View Abstract
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. View Abstract
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases. View Abstract
Response to: Treatment of (Recurrent) Clostridioides difficile Infections in Children and Adults. View Abstract
Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review. View Abstract
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children. View Abstract
The Gut Microbiome: A Difficult Target for Translational Studies of Clostridium difficile Colonization. View Abstract
Risk-factors Associated with Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review. View Abstract
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. View Abstract
Searching for superstool: maximizing the therapeutic potential of FMT. View Abstract
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. View Abstract
Moving On: Transition Readiness in Adolescents and Young Adults With IBD. View Abstract
Indirect Costs and Family Burden of Pediatric Crohn's Disease in the United States. View Abstract
Reliability and validity of the Beliefs About Medication Scale in pediatric inflammatory bowel disease. View Abstract
Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics. View Abstract
What Teens Do Not Know Can Hurt Them: An Assessment of Disease Knowledge in Adolescents and Young Adults with IBD. View Abstract
Transition of Care for Adolescents and Young Adults With Inflammatory Bowel Disease: The More We Learn, The Less We Know. View Abstract
Transition of Care for Adolescents and Young Adults with IBD: The More We Learn, the Less We Know. View Abstract
The Transition From Pediatric to Adult Inflammatory Bowel Disease Care. View Abstract
When Subjects Violate the Research Covenant: Lessons Learned from a Failed Clinical Trial of Fecal Microbiota Transplantation. View Abstract
Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBD. View Abstract
Colonic Necrosis in a 4-Year-Old with Hyperlipidemic Acute Pancreatitis. View Abstract
Genetic and Metabolic Signals during Acute Enteric Bacterial Infection Alter the Microbiota and Drive Progression to Chronic Inflammatory Disease. View Abstract
Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease. View Abstract
Can You Teach a Teen New Tricks? Problem Solving Skills Training Improves Oral Medication Adherence in Pediatric Patients with Inflammatory Bowel Disease Participating in a Randomized Trial. View Abstract
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. View Abstract
Can we improve on the "see one, do one, teach one" paradigm in training fellows to care for patients with inflammatory bowel disease? View Abstract
Transition of Care in Inflammatory Bowel Disease. View Abstract
Trajectories of oral medication adherence in youth with inflammatory bowel disease. View Abstract
Fecal microbiota transplantation: an interest in IBD? View Abstract
Patient perceptions of fecal microbiota transplantation for ulcerative colitis. View Abstract
Colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection in a child. View Abstract
An unusual case of an infant with failure to thrive. View Abstract
What's in a name generator? Choosing the right name generators for social network surveys in healthcare quality and safety research. View Abstract
Studying the Enteric Microbiome in Inflammatory Bowel Diseases: Getting through the Growing Pains and Moving Forward. View Abstract
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we? View Abstract
Massive intestinal bleeding in a child with superior mesenteric artery aneurysm and gastrointestinal tuberculosis. View Abstract